Peripheral neuropathy in severe COVID-19 resolved with therapeutic plasma exchange

被引：20

作者：

Faqihi, Fahad ^{[1
]}

Alharthy, Abdulrahman ^{[1
]}

Memish, Ziad A. ^{[2
]}

Kutsogiannis, Demetrios J. ^{[3
]}

Brindley, Peter G. ^{[3
]}

Karakitsos, Dimitrios ^{[1
,4
]}

机构：

[1] King Saud Med City, Crit Care Dept, POB 331905, Riyadh 11373, Saudi Arabia

[2] King Saud Med City, Res & Innovat Ctr, Riyadh, Saudi Arabia

[3] Univ Alberta, Fac Med & Dent, Dept Crit Care, Edmonton, AB, Canada

[4] USC, Keck Sch Med, Crit Care Dept, Los Angeles, CA USA

来源：

CLINICAL CASE REPORTS | 2020年 / 8卷 / 12期

关键词：

COVID-19; cytokine release syndrome; peripheral neuropathy; therapeutic plasma exchange; GUILLAIN-BARRE-SYNDROME; NERVE-CONDUCTION; MORTALITY;

D O I：

10.1002/ccr3.3397

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Peripheral neuropathies including Guillain-Barre syndrome may be linked to life-threatening COVID-19. Plasma exchange is a safe rescue therapy in severe COVID-19 with associated neurological manifestations and thromboinflammation.

引用

页码：3233 / 3238

页数：6

共 50 条

[31] Therapeutic plasma exchange in the treatment of COVID-19 induced cytokine storm: the first Moroccan experience (vol 23, 829, 2023)
Bouayed, Mohamed Zakaria
Laaribi, Ilyass
Benaini, Iliass
Yeznasni, Asmae
Berrajaa, Sara
Oujidi, Younes
Bkiyar, Houssam
Abda, Naima
Housni, Brahim
BMC INFECTIOUS DISEASES, 2023, 23 (01)
[32] The efficacy of therapeutic plasma exchange in COVID-19 patients on endothelial tightness in vitro is hindered by platelet activation
Ebermeyer, Theo
Hequet, Olivier
Berard, Frederic
Prier, Amelie
Eyraud, Marie-Ange
Arthaud, Charles-Antoine
Heestermans, Marco
Duchez, Anne-Claire
Guironnet-Paquet, Aurelie
Berthelot, Philippe
Cognasse, Fabrice
Hamzeh-Cognasse, Hind
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
[33] Does therapeutic plasma exchange have a role in resistant cytokine storm state of COVID-19 infection?
Elsayed, Mohamed Mamdouh
Zeid, Montasser Mohamed
Fayed, Akram Mohamed
Elreweny, Ehab Mahmoud
Zakaria, Nermine Hossam
Baess, Ayman Ibrahim
ALEXANDRIA JOURNAL OF MEDICINE, 2021, 57 (01) : 235 - 239
[34] Evaluating the elimination status of medications used for COVID-19 during hemoperfusion and therapeutic plasma exchange: A review
Shokouhi, Shervin
Barati, Saghar
Kazeminia, Neda
Jamali, Faezeh
Roshan, Baran
Sahraei, Zahra
INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 97
[35] The Impact of Severe COVID-19 on Plasma Antioxidants
Zarkovic, Neven
Jastrzab, Anna
Jarocka-Karpowicz, Iwona
Orehovec, Biserka
Barsic, Bruno
Tarle, Marko
Kmet, Marta
Luksic, Ivica
Luczaj, Wojciech
Skrzydlewska, Elzbieta
MOLECULES, 2022, 27 (16):
[36] The effect of therapeutic plasma exchange therapy on veno-venous ECMO weaning success in severe COVID-19 ARDS patients
Aslan, Murat
Yilmaz, Rabia
Dogan, Murat
Cukurova, Zafer
THERAPEUTIC APHERESIS AND DIALYSIS, 2023, 27 (04) : 780 - 789
[37] Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients
Tabibi, Seena
Tabibi, Tara
Conic, Rosalynn R. Z.
Banisaeed, Nassim
Streiff, Michael B.
JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (09) : 827 - 835
[38] Convalescent Plasma for the Treatment of Severe COVID-19
Franchini, Massimo
Liumbruno, Giancarlo Maria
BIOLOGICS-TARGETS & THERAPY, 2021, 15 : 31 - 38
[39] Critical illness neuropathy in severe COVID-19: a case series
Tommaso Bocci
Laura Campiglio
Manuela Zardoni
Stefano Botta
Silvia Coppola
Elisabetta Groppo
Davide Chiumello
Alberto Priori
Neurological Sciences, 2021, 42 : 4893 - 4898
[40] Critical illness neuropathy in severe COVID-19: a case series
Bocci, Tommaso
Campiglio, Laura
Zardoni, Manuela
Botta, Stefano
Coppola, Silvia
Groppo, Elisabetta
Chiumello, Davide
Priori, Alberto
NEUROLOGICAL SCIENCES, 2021, 42 (12) : 4893 - 4898

← 1 2 3 4 5 →